Sep. 8 at 12:03 PM
$ATHE Raises
$20.0M AUD in Strategic Placement
https://www.globenewswire.com/news-release/2025/09/08/3146023/0/en/Alterity-Therapeutics-Raises-A-20-0-million-in-Strategic-Placement.html
The Placement was conducted at A
$0.012 per share, representing a discount of 7.7% to the last ASX closing price prior to the trading halt and a 7.3% discount to the 10-day volume weighted average price (vwap).
The ASX trades ordinary shares. NASDAQ trades ADS's. So we have to convert the price to USD and convert the price per ordinary share to price per ADS:
•
$20.0M AUD = approx
$13.18M USD
•
$0.012 AUD per ordinary share =
$0.0079 USD per ordinary share.
• For ATHE, 1 ADS = 600 ordinary shares.
• Price per ADS in USD = approx
$4.74 (
$0.0079 x 600)
• ASX filing states that the max number of ordinary shares is 1,666,666,663 (screenshot). Which is equal to approx 2,777,778 ADS.
•
$13.18M USD / 2.78m ADS = approx
$4.74 per ADS.
• As of Jun 30, there were 9,127,370,686 ordinary shares outstanding. Which equals approx 15.2m ADS. After this offering, they should have approx 18m ADS outstanding on NASDAQ.
